M&A in the Chemical Industry

Navigating Uncertainty While Unlocking Strategic Opportunities

Wolfgang Kazmierowski and Christian Dehm, DC Advisory

M&A activities in the chemical industry are on the rise again, and companies with a clear strategy and consistent action will be particularly successful in the future.
© gothong_1984 - stock.adobe.com

Mergers and acquisitions (M&A) are both a driver and a reflection of consolidation in the chemical industry. They allow companies to adapt to a challenging environment, leverage synergies and strengthen their market position. Consolidation in the industry will continue, particularly in segments with persistent margin pressure, but also where investors can benefit from long-term trends such as sustainability and innovation.

The global chemical M&A market is facing a period of significant complexity. Investor confidence has been unsettled by a mix of geopolitical tensions, inflation, and regulatory shifts, creating a cautious environment for dealmaking. While general market sentiment remains mixed, we believe both investors and sellers are active in principle. 

Financial sponsors with dry powder are scanning the market for the right opportunities, while several large chemical groups are preparing to divest non-core assets as part of broader portfolio restructuring.

Read more with free registration

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Sign in or register

Company

Logo:

DCAT - Drug, Chemical & Associated Technologies Association

One Union St., Suite 208
Robbinsville
US

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.